Search Results - Roman Zelchan
- Showing 1 - 5 results of 5
-
1
-
2
The GRPR Antagonist [<sup>99m</sup>Tc]Tc-maSSS-PEG<sub>2</sub>-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity by Ayman Abouzayed, Jesper Borin, Fanny Lundmark, Anastasiya Rybina, Sophia Hober, Roman Zelchan, Vladimir Tolmachev, Vladimir Chernov, Anna Orlova
Published in Diagnostics (2023-05-01)Get full text
Article -
3
Phase I Clinical Trial Using [<sup>99m</sup>Tc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients by Vladimir Chernov, Ekaterina Dudnikova, Roman Zelchan, Anna Medvedeva, Anstasiya Rybina, Olga Bragina, Viktor Goldberg, Albina Muravleva, Jens Sörensen, Vladimir Tolmachev
Published in Pharmaceutics (2022-06-01)Get full text
Article -
4
Phase I Clinical Study with the GRPR-Antagonist [<sup>99m</sup>Tc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference? by Anna Orlova, Anastasia Rybina, Anna Medvedeva, Roman Zelchan, Olga Bragina, Liubov Tashireva, Maria Larkina, Ruslan Varvashenya, Nadejda Lushnikova, Panagiotis Kanellopoulos, Theodosia Maina, Berthold A. Nock, Vladimir Tolmachev, Vladimir Chernov
Published in Pharmaceutics (2025-10-01)Get full text
Article -
5
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [<sup>99m</sup>Tc]Tc-DB8 by Olga Bragina, Vladimir Chernov, Mariia Larkina, Ruslan Varvashenya, Roman Zelchan, Anna Medvedeva, Anastasiya Ivanova, Liubov Tashireva, Theodosia Maina, Berthold A. Nock, Panagiotis Kanellopoulos, Jens Sörensen, Anna Orlova, Vladimir Tolmachev
Published in Pharmaceutics (2025-07-01)Get full text
Article